BRAF immunohistochemistry in melanoma

The pathologist assesses where and how strongly melanoma cells stain. The finding can support treatment planning, although it must be interpreted with the pathology report and may need confirmation using a molecular test.

Positive staining indicates that the tested melanoma tissue contains the altered protein recognised by the antibody. This can point to a BRAF alteration that may be relevant when the oncology team considers targeted medicines. It does not establish whether melanoma has spread, and it does not predict an individual response on its own.

Negative staining only says that the stain's target was not found in that specimen. Other BRAF alterations can be missed because the antibody is designed for a specific protein change. An unclear result can occur when tumour is scarce, tissue quality is reduced, or background staining complicates the microscopic reading.

Your team may compare the stain with DNA-based BRAF testing before choosing treatment, especially if the staining pattern is uncertain or the clinical decision requires a fuller assessment of BRAF alterations. The final plan may also reflect where the melanoma is, whether it has spread, whether surgery is possible, other tumour markers, previous therapy, and your overall health. Do not start, stop, or change cancer medicine based only on a pathology phrase.

The laboratory result itself does not require emergency care. Contact your cancer team promptly for a quickly worsening symptom, a rapidly changing skin lesion, new persistent neurological symptoms, uncontrolled pain, or repeated vomiting. Get urgent help for severe breathing difficulty, a seizure, collapse, sudden confusion, or new weakness affecting one side of the body.

Useful questions include: Which BRAF protein change was tested? Is molecular confirmation needed? Was there enough melanoma tissue for a dependable interpretation? Ask whether the result changes your available treatments, which benefits and side effects matter for those options, and whether another sample would add useful information.